News & Updates

A triplet regimen comprising the anti-CD30 antibody-drug conjugate (ADC) brentuximab vedotin (BV) plus lenalidomide and rituximab (R2) inches its way into the R/R DLBCL* treatment path in the prespecified interim analysis of the ECHELON-3 trial, further reinforcing the role of BV in lymphoma treatment.

The inclusion of remdesivir in the SoC is significantly associated with a 54-percent lower risk of death at day 28 among hospitalized adults with COVID-19 who require O₂ support, suggests a cross-study comparison that weight-balances patients from a clinical trial with those from a real-world study

People with schizophrenia may benefit from cognitive remediation which offers durable improvements in both cognition and psychosocial functioning, as shown in a study.

In patients with type 1 diabetes (T1D) treated with SGLT2 inhibitors, such as dapagliflozin, the addition of pioglitazone helps to intensify the reduction in HbA1c and blocks the increase in plasma ketone driven by SGLT2 inhibitors, reports a study presented at ADA 2024. This enables long-term cardiovascular and renal outcome studies to be safely performed in T1D patients.

Surgical lung biopsy (SLB) neither reduces lung function nor increases the risk of death or lung transplantation in patients with idiopathic pulmonary fibrosis (IPF), reports a study.